✦ LIBER ✦

Biological variables in thoracic neuroblastoma: A Pediatric Oncology Group study

✍ Scribed by Jonathan A Morris; Stephen J Shochat; E.Ide Smith; A.Thomas Look; Garrett M Brodeur; Alan B Cantor; Robert P Castleberry

Book ID: 115994509
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 768 KB
Volume: 30
Category: Article
ISSN: 0022-3468
DOI: 10.1016/0022-3468(95)90577-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thoracic neuroblastoma: A pediatric onco

Thoracic neuroblastoma: A pediatric oncology group study

✍ Gregg A. Adams; Stephen J. Shochat; E. Ide Smith; Jonathan J. Shuster; Vijay V. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 839 KB

A biochemical analysis of thoracic neuro

A biochemical analysis of thoracic neuroblastomas: A pediatric oncology group study

✍ Stephen J. Shochat; Nancy L. Corbelletta; Mary Ann Repman; Cara-Lynne Schengrund 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 485 KB

Lymph node sampling in localized neurobl

Lymph node sampling in localized neuroblastoma: A Pediatric Oncology Group study

✍ Monica P Contador; Stuart Johnston; E Ide Smith; Jonathan J Shuster; F Ann Hayes 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 783 KB

Ganglioside composition of human neurobl

Ganglioside composition of human neuroblastomas correlation with prognosis A pediatric oncology group study

✍ Cara-Lynne Schengrund; Mary Ann Repman; Stephen J. Shochat 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

The ganglioside composition of neuroblastoma samples from 53 patients was determined. Tumor sites included the adrenal5 (15), and the thoracic (to), abdominal (15), and pelvic (3) areas. Age of the patients at the time of surgery ranged from 1 day to over 10 years and the Stage of the tumors from A

Detection of MYCN Gene Amplification in

Detection of MYCN Gene Amplification in Neuroblastoma by Fluorescence In Situ Hybridization: A Pediatric Oncology Group Study

✍ Mathew, Prasad; Valentine, Marcus B.; Bowman, Laura C.; Rowe, Susan T.; Nash, Mi 📂 Article 📅 2001 🏛 Neoplasia Press 🌐 English ⚖ 292 KB

Cisplatin in recurrent pediatric brain t

Cisplatin in recurrent pediatric brain tumors A pog phase II study a pediatric oncology group study

✍ Charles L. Sexauer; Atiya Khan; Peter C. Burger; Jeffrey P. Krischer; Jan Van Ey 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 2 views

Forty-six evaluable pediatric patients with primary recurrent brain tumors resistant to standard therapy were treated with cisplatin, 60 mg/m\*/day, X2 days every 3 to 4 weeks, to study the efficacy and toxicity of this drug. Complete and partial responses, documented by computed tomography (CT) sca